Related Experiment Video
Updated: Jul 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
ACR Appropriateness Criteria on treatment of anal cancer
Matthew M Poggi1, W Warren Suh, Leonard Saltz
1National Naval Medical Center, Department of Radiation Oncology, Bethesda, Md 20889-5000, USA. mmpoggi@bethesda.med.navy.mil
Abstract:
Anal cancer is a relatively rare neoplasm, accounting for roughly 4,500 cases per year. The evolution of the definitive treatment of anal cancer from a surgical to a nonsurgical approach, however, has been viewed as a model disease site in a larger paradigm shift in medicine. Organ preservation, in this case a functional anal sphincter, and durable cure are obtainable goals. To this end, anal cancer is a disease best treated primarily with chemoradiation. Although appropriate treatment can produce acceptable results, further investigation and improvement in therapy are still needed.